RT Journal Article
SR Electronic
T1 Will oral antithrombin agents replace warfarin?
JF Heart
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 827
OP 828
DO 10.1136/hrt.2003.030379
VO 90
IS 8
A1 P R Sinnaeve
A1 F J Van de Werf
YR 2004
UL http://heart.bmj.com/content/90/8/827.abstract
AB The new oral direct thrombin inhibitor ximelagatran is at least equivalent to warfarin for stroke prevention in patients with non-valvar atrial fibrillation, and seems to be a promising adjunct to aspirin after acute coronary syndrome